The president of the Pharmaceutical Industries Association (ADIFAN), José Silva, explained that Peruvian laboratories are at disadvantage compared to foreign manufacturers who are favored by tariff exemptions. Due to this situation, Peruvian laboratories manufacture less quantity of medicines, causing up to 70% of medicines in Perú to be imported and only the remaining 30% to
The Indian pharmaceutical industry, in 2016, exported a total of USD 41 million to the Peruvian market, becoming the sixth largest supplier of pharmaceutical products in Peru. Ten health institutions in Peru represent 41% of imports of pharmaceutical products. The Ministry of Health ranks first with USD 66 million, representing 9% of the total imported